Company: OSRH
Filing Date: 2025-04-22
Form Type: 10-K
Source: 0001213900-25-034116
Chunk: 186

Company: OSR Holdings, Inc.
Filing Date: 2025-04-22
Form: 10-K
Item: Item 1
Chunk 186
---
 materially affect, our internal control over financial reporting.

Item  9B.Other Information

None.

Item  9C.Disclosure Regarding Foreign Jurisdictions that Prevent
Inspection

Not applicable. 

93

PART III 

Item 10. Directors, Executive Officers and Corporate Governance 

As of the date of this report, our current directors and executive
officers are as follows:

    Name
     
    Age
     
    Position 
  
    Kuk Hyoun Hwang
     
    49
     
    Chief Executive Officer and President
  
    Jun Chul Whang
     
    60
     
    Chief Legal Officer and Secretary
  
    Sang Hoon Kim
     
    51
     
    Head of Corporate Venture Capital
  
    Gihyoun Bang
     
    47
     
    Chief Financial Officer
  
    Constance Höfer 
     
    56
     
    Chief Scientific Officer
  
    Phil Geon Lee
     
    57
     
    Lead Independent Director
  
    Alcide Barberis
     
    66
     
    Independent Director
  
    Seng Chin Mah
     
    65
     
    Independent Director
  
    Jin Whan Park
     
    57
     
    Independent Director
  
    Sang Hyun Kim
     
    54
     
    Independent Director
  
    Hyuk Joo Jee
     
    57
     
    Independent Director
  
    Joong Myung Cho
     
    75
     
    Independent Director

Kuk Hyoun Hwang has been the Chief Executive Officer and a director
of OSR since March 2020. Mr. Hwang is also the President and Chief Executive Officer of the Company as of the Closing of the Business
Combination. Mr. Hwang is the Managing Partner of BCM, which he founded in August 2012. Since then, he has led BCM’s and its subsidiaries’
growth and expansion as a cross-border healthcare investment group in three countries: the U.S., South Korea and Switzerland. He is also
the Chief Executive Officer of BCME, a position he has held since March 2020, and the Chairman of the Board of Vaximm AG since November
2022. Since July 2019 until April 2021 and December 2022 to August 2024, Mr. Hwang has also served as